EXTEDO Announces First Commercial Validation Solution to Support the New EU eCTD Module 1 Version 3.0

Ottobrunn, Germany, March 31, 2016 (Newswire.com) - EXTEDO, a leading regulatory information management solutions provider to the life sciences industry, announced today that the latest update of their long standing eCTD validation solution, EURSvalidator, is now compliant with the new European eCTD Module 1 version 3.0 specifications.

Starting from July 1st 2016, regulatory submissions complying with the new eCTD M1 v3.0 specification can be filed with the EMA. During a transitionary period, ending on October 1st 2016, the EMA will continue to accept version 2.0 submissions, after this time v3.0 will become mandatory for all filings.

Trusted by regulatory authorities across the world, including the European Medicines Agency (EMA), EXTEDO’s EURSvalidator is the first commercial validation solution to support the new eCTD Module 1 version 3.0 standard.

For more information on the upcoming regulatory changes, please visit: http://bit.ly/233N4ZB